|
TEX261 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.00669999950165E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
5.676000E-02 |
| Stage1-vs-Stage3 |
5.584300E-02 |
| Stage1-vs-Stage4 |
2.076300E-02 |
| Stage2-vs-Stage3 |
4.439900E-03 |
| Stage2-vs-Stage4 |
1.261120E-03 |
| Stage3-vs-Stage4 |
3.934400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.31109999967904E-07 |
| Normal-vs-Asian |
5.05928632321684E-13 |
| Caucasian-vs-AfricanAmerican |
3.399200E-01 |
| Caucasian-vs-Asian |
3.452000E-01 |
| AfricanAmerican-vs-Asian |
8.210800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
7.009000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.017060E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.496400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.988600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.958400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.373000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.427400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.109200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.42439999981792E-08 |
| Classical-VS-Follicular |
1.721490E-03 |
| Classical-VS-Other |
4.876800E-01 |
| Classical-VS-Normal |
1.63058455626697E-12 |
| Tall-VS-Follicular |
1.73629999267177E-10 |
| Tall-VS-Other |
2.752000E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.351780E-01 |
| Follicular-VS-Normal |
5.48669998323703E-10 |
| Other-VS-Normal |
5.79349999999534E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
1.18559999995327E-06 |
|
|
